NASDAQ: VRTX
Vertex Pharmaceuticals Inc Stock Ownership - Who owns Vertex Pharmaceuticals?

Insider buying vs selling

Have Vertex Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ourania TatsisEVP Chief Reg. Quality Off.2026-07-021,500$524.99
$787.49kSell
Duncan McKechnieEVP Chief Commercial Officer2026-07-021,541$519.00
$799.78kSell
Joy LiuEVP and Chief Legal Officer2026-07-01828$502.71
$416.24kSell
Carmen BozicEVP and CMO2026-06-26596$482.50
$287.57kSell
Carmen BozicEVP and CMO2026-06-181,020$462.17
$471.41kSell
Carmen BozicEVP and CMO2026-06-154,062$450.00
$1.83MSell
Carmen BozicEVP and CMO2026-06-051,745$450.00
$785.25kSell
Joy LiuEVP and Chief Legal Officer2026-06-01828$439.91
$364.25kSell
Carmen BozicEVP and CMO2026-05-291,974$450.00
$888.30kSell
Mark E. BunnageEVP Chief Scientific Officer2026-05-1533$453.45
$14.96kSell

1 of 15

VRTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VRTX insiders and whales buy or sell their stock.

VRTX Shareholders

What type of owners hold Vertex Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Capital World Investors10.00%25,368,124$12.10BInstitution
Blackrock Inc9.44%23,969,517$11.44BInstitution
Capital Research Global Investors8.32%21,125,964$10.08BInstitution
Vanguard Capital Management LLC6.51%16,512,810$7.88BInstitution
State Street Corp4.62%11,730,139$5.60BInstitution
Jpmorgan Chase Co2.77%7,033,156$3.36BInstitution
Geode Capital Management LLC2.42%6,139,621$2.93BInstitution
Vanguard Portfolio Management LLC2.03%5,145,609$2.45BInstitution
Capital International Investors2.02%5,126,077$2.45BInstitution
Loomis Sayles Co L P1.58%4,003,821$1.91BInstitution

1 of 3

VRTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VRTX91.52%1.52%Net SellingNet Selling
REGN68.59%31.41%Net SellingNet Selling
ARGX46.08%0.00%
RVMD91.08%8.92%Net SellingNet Selling
ONC2.41%31.88%Net SellingNet Selling

Vertex Pharmaceuticals Stock Ownership FAQ

Who owns Vertex Pharmaceuticals?

Vertex Pharmaceuticals (NASDAQ: VRTX) is owned by 91.52% institutional shareholders, 1.52% Vertex Pharmaceuticals insiders, and 6.97% retail investors. Capital World Investors is the largest individual Vertex Pharmaceuticals shareholder, owning 25.37M shares representing 10.00% of the company. Capital World Investors's Vertex Pharmaceuticals shares are currently valued at $12.10B.

If you're new to stock investing, here's how to buy Vertex Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.